Circulating cell‐free HPV DNA is a strong marker for disease severity in cervical cancer

S Bønløkke, T Steiniche, BS Sorensen… - Molecular …, 2024 - Wiley Online Library
For cervical cancer (CC), circulating cell‐free HPV DNA (ccfHPV) may establish disease
severity. Furthermore, HPV integration has been correlated to viral load and survival. In this …

Clinical applications and utility of ctDNA in cervical cancer and its precursor lesions: from screening to predictive biomarker

L Li, Y Tong, J Wu, X Xu - Cancer Cell International, 2023 - Springer
Cervical cancer is a leading cause of gynecological cancer death in the world. Human
papillomavirus (HPV) is the most causative factor of cervical cancer. In addition, many …

Targeted next generation sequencing for human papillomavirus genotyping in cervical liquid-based cytology samples

K Andersen, K Holm, M Tranberg, CL Pedersen… - Cancers, 2022 - mdpi.com
Simple Summary Testing for Human Papillomavirus (HPV) is currently being implemented
as part of cervical cancer (CC) screening in several countries. However, infections with all …

Screening Methods for Cervical Cancer

J Li, SD Adobo, H Shi, KAW Judicael, N Lin… - …, 2024 - Wiley Online Library
Cervical cancer seriously affects the health of women worldwide. Persistent infection of high‐
risk HPV (Human Papilloma Virus) can lead to cervical cancer. There is a great need for …

Feasibility and accuracy of menstrual blood testing for high-risk human papillomavirus detection with capture sequencing

J Zhang, X Tian, Y Chen, S Huang, Z Cui… - JAMA network …, 2021 - jamanetwork.com
Importance High-risk human papillomavirus (hrHPV) persistent infection is the major
etiology of cervical precancer and cancer. Noninvasive self-sampling HPV testing is a …

HPV Status and individual characteristics of human papillomavirus infection as predictors for clinical outcome of locally advanced cervical cancer

L Mkrtchian, I Zamulaeva, L Krikunova… - Journal of Personalized …, 2021 - mdpi.com
This study is aimed at searching for an informative predictor of the clinical outcome of
cervical cancer (CC) patients. The study included 135 patients with locally advanced …

Searching for the methylation sites involved in human papillomavirus type 16 and 18‑positive women with cervical cancer

Y Ma, C Wang, M Shi, M Li, L Li… - … and clinical oncology, 2022 - spandidos-publications.com
It has been reported that> 90% of women with cervical cancer are human papillomavirus
(HPV)‑positive, with HPV16 and 18 being the most 'highest‑risk'HPV genotypes. However, in …

Analytical evaluation of the automated genotyping system (GenPlex) compared to a traditional real‐time PCR assay for the detection of high‐risk human …

L Zhang, Y Ju, H Hu, C Ma, Y Yu… - Journal of Medical …, 2024 - Wiley Online Library
The detection of high‐risk human papillomaviruses (HPVs) is crucial for early screening and
preventing cervical cancer. However, the substantial workload in high‐level hospitals or the …

[HTML][HTML] 靶向第二代测序技术在病原体检测中的作用

罗宁, 何泰瑜, 康娟, 张大志 - Advances in Clinical Medicine, 2024 - hanspub.org
病原学的早期准确识别对于感染性疾病的诊治至关重要. 随着基因检测技术的发展,
第二代测序技术正被逐步应用于临床病原体的检测. 作为第二代测序技术的一个分类 …

Genetic Testing in Cervical Cancer

A Sharma, R Singh - Genetic Testing in Reproductive Medicine, 2024 - Springer
Cervical cancer, a prevalent disease in developing countries, is responsible for a huge
number of deaths due to gynecological cancers. Human papillomavirus (HPV) infection is …